Neogenomics Inc. (NASDAQ: NEO) stock jumped 0.52% on Monday to $19.51 against a previous-day closing price of $19.41. With 0.82 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.93 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $19.57 whereas the lowest price it dropped to was $19.05. The 52-week range on NEO shows that it touched its highest point at $20.54 and its lowest point at $8.70 during that stretch. It currently has a 1-year price target of $21.00. Beta for the stock currently stands at 1.34.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NEO was up-trending over the past week, with a rise of 21.33%, but this was up by 40.36% over a month. Three-month performance surged to 38.57% while six-month performance rose 6.44%. The stock gained 95.49% in the past year, while it has gained 111.15% so far this year. A look at the trailing 12-month EPS for NEO yields -0.77 with Next year EPS estimates of -0.08. For the next quarter, that number is -0.03. This implies an EPS growth rate of 67.86% for this year and 57.69% for next year.
Float and Shares Shorts:
At present, 126.91 million NEO shares are outstanding with a float of 125.79 million shares on hand for trading. On Oct 30, 2023, short shares totaled 6.15 million, which was 4.83% higher than short shares on Sep 28, 2023. In addition to NIO as the firm’s NIO Inc., NVO serves as its Novo Nordisk A/S.
Through their ownership of 93.40% of NEO’s outstanding shares, institutional investors have majority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NEO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With NEO analysts setting a high price target of $30.00 and a low target of $16.00, the average target price over the next 12 months is $21.00. Based on these targets, NEO could surge 53.77% to reach the target high and fall by -17.99% to reach the target low. Reaching the average price target will result in a growth of 7.64% from current levels.
Summary of Insider Activity:
Insiders traded NEO stock several times over the past three months with 0 Buys and 2 Sells. In these transactions, 0 shares were bought while 1,680 shares were sold. The number of buy transactions has increased to 6 while that of sell transactions has risen to 9 over the past year. The total number of shares bought during that period was 332,972 while 29,477 shares were sold.